Alzheimer's disease (AD), the leading cause of dementia, is characterized by amyloid‐β accumulation, tau hyperphosphorylation, neuroinflammation, and synaptic failure, with no curative therapies available. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.